These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer.
    Author: Perez EA, Gandara DR.
    Journal: Semin Oncol; 1994 Jun; 21(3 Suppl 4):2-5. PubMed ID: 8209273.
    Abstract:
    Although non-small cell lung cancer has long been considered poorly responsive to chemotherapy, there are now a number of chemotherapeutic agents with reproducible activity in this disease, including cisplatin and ifosfamide. Another agent, etoposide, has been rationally incorporated into combination regimens for this disease based on demonstrated preclinical synergy. We review recent studies combining these three agents in the treatment of metastatic non-small cell lung cancer as well as prospects for further development.
    [Abstract] [Full Text] [Related] [New Search]